Detail page

Knowledge Web

Person

Christian Könecke (1976-)

Arzt

Name	Christian Könecke
Time	1976- (Date of birth and death)
Place	Hannover (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med. (an der Medizinischen Hochschule) (2004)
Profession	Arzt (characteristic profession)
Variant	Christian Koenecke
Related	Medizinische Hochschule Hannover Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
Further information	Habil.-Schr.im Fach Innere Medizin und Hämatologie und Onkologie der Medizinischen Hochschule Hannover, 2012
Record type	Person
GND-Identifier	129502162
Record ID	129502162
Involved in show all Correction: Pourroy et al. High-dose methotrexate at all ages: safety, efficacy, and outcomes from the HDMTX European registry. Cancers 2026, 18, 124 Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party High-dose methotrexate at all ages: safety, efficacy, and outcomes from the HDMTX European registry Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party Management of Patients Undergoing CAR-T Cell Therapy in Germany ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation? Deciphering antigen specificity of regulatory T cell clones in patients after allogeneic stem cell transplantation Kinetik des T-Zell-Rezeptor-Repertoires bei der Graft-Versus-Host Erkrankung nach Spender-Lymphozyten-Infusion Management of patients undergoing CAR-T cell therapy in Germany Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies Entwicklung onkolytischer Viren mit T-Zellaktivierenden Eigenschaften für die Immuntherapie solider Tumore Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial Target capture sequencing reveals a monoclonal outbreak of respiratory syncytial virus B infections among adult hematologic patients Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network Neurological management and work-up of neurotoxicity associated with CAR T cell therapy Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT Acute regulation of Tie2 in sepsis Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas 18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up Establishment of murine organoids with defined states of differentiation as a model for colonic ion transport Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells Publisher Correction: Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection Sinusoidal Obstruction Syndrome of the Liver after Hematopoietic Stem Cell Transplantation: Decision Making for Orthotopic Liver Transplantation Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation Disruption of de novo fatty acid synthesis via acetyl‐CoA carboxylase 1 inhibition prevents acute graft‐versus‐host disease Optimierung der Behandlungsstrategien nach allogener hämatopoetischer Stammzelltransplantation : experimentelle und klinische Untersuchungen High TCR diversity ensures optimal function andhomeostasis of Foxp3 + regulatory Tcells Alloantigen‐specific de novo‐ induced Foxp3 + Treg revert in vivo and do not protect from experimental GVHD Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia NK-Zell-Rekonstitution, Chimärismus, Funktion und Erkennung in Empfängern einer haploidentischen hämatopoetischen Stammzelltransplantation nach einer nicht-myeloablativen Konditionierung

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Christian Könecke (1976-)

Correction: Pourroy et al. High-dose methotrexate at all ages: safety, efficacy, and outcomes from the HDMTX European registry. Cancers 2026, 18, 124

Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party

High-dose methotrexate at all ages: safety, efficacy, and outcomes from the HDMTX European registry

Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study

Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study

Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party

Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study

PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation

ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party

Management of Patients Undergoing CAR-T Cell Therapy in Germany

ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?

Deciphering antigen specificity of regulatory T cell clones in patients after allogeneic stem cell transplantation

Kinetik des T-Zell-Rezeptor-Repertoires bei der Graft-Versus-Host Erkrankung nach Spender-Lymphozyten-Infusion

Management of patients undergoing CAR-T cell therapy in Germany

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial

Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study

The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

Entwicklung onkolytischer Viren mit T-Zellaktivierenden Eigenschaften für die Immuntherapie solider Tumore

Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience

Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q

SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients

Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT

Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience

Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial

Target capture sequencing reveals a monoclonal outbreak of respiratory syncytial virus B infections among adult hematologic patients

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network

Neurological management and work-up of neurotoxicity associated with CAR T cell therapy

Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT

Acute regulation of Tie2 in sepsis

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma

Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up

Establishment of murine organoids with defined states of differentiation as a model for colonic ion transport

Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT

Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT

Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation

Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells

Publisher Correction: Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection

Sinusoidal Obstruction Syndrome of the Liver after Hematopoietic Stem Cell Transplantation: Decision Making for Orthotopic Liver Transplantation

Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation

VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation

Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation

Disruption of de novo fatty acid synthesis via acetyl‐CoA carboxylase 1 inhibition prevents acute graft‐versus‐host disease

Optimierung der Behandlungsstrategien nach allogener hämatopoetischer Stammzelltransplantation : experimentelle und klinische Untersuchungen

High TCR diversity ensures optimal function andhomeostasis of Foxp3 + regulatory Tcells

Alloantigen‐specific de novo‐ induced Foxp3 + Treg revert in vivo and do not protect from experimental GVHD

Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia

NK-Zell-Rekonstitution, Chimärismus, Funktion und Erkennung in Empfängern einer haploidentischen hämatopoetischen Stammzelltransplantation nach einer nicht-myeloablativen Konditionierung